Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.10
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 344,271
  • Market Cap: £345.96m
  • RiskGrade: 119
  • Beta: 0.00

Company Description

Peerless Technology is a shell company co-founded by Peter Wilkinson, the serial internet entrepreneur who founded Freeserve.

IPO Details

Issue Date 22-Nov-2001 Prospectus n/a
Issue Price 20.00p Lead Broker Numis Securities
Market Cap £3.00m Contact Tel 0207 776 1500
Method Placing    
Sector Investment companies    
Market Aim    
Amount Raised £2.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.10
52 Week Low 29.35
Volume 344,271
Shares Issued 540.57m
Market Cap £345.96m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.3% below the market average65.3% below the market average65.3% below the market average65.3% below the market average65.3% below the market average
10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average
Price Trend
73.46% above the market average73.46% above the market average73.46% above the market average73.46% above the market average73.46% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average
Income Not Available
Growth
32.87% below the market average32.87% below the market average32.87% below the market average32.87% below the market average32.87% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 11-Mar-2025

Time Volume / Share Price
11:00 1 @ 64.00p
11:00 1 @ 64.10p
11:00 20 @ 64.00p
10:48 200,000 @ 64.05p
10:46 191 @ 64.06p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page